Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Gentian Diagnostics ASA Share Issue/Capital Change 2020

Dec 17, 2020

3604_rns_2020-12-17_4852bf7e-0d50-4eee-bbfa-9a0866365e60.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Share capital increase registered

Share capital increase registered

Moss, 17.12.2020

Reference is made to the stock exchange notice from Gentian Diagnostics AS (the "Company") on 4 December 2020 regarding a share issue in connection with an employee share purchase program (ESPP), by issuance of 9,171 new shares in the Company at a subscription price of NOK 50.38 per new share. The share capital increase pertaining to the ESPP is now registered with the Norwegian Register of Business Enterprises. The Company's new registered share capital is NOK 1,541,188.9 divided on 15,411,889 shares, each with a nominal value of NOK 0.10.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

For further information, please contact:

Hilja Ibert

CEO, Gentian Diagnostics

E-mail: [email protected]

Cell Phone: +47 919 05 242

Njaal Kind

CFO, Gentian Diagnostics

E-mail: [email protected]

Cell Phone: +47 919 06 525